Are calcium channel blockers associated with breast cancer? Assessing the impact of long-term use in large longitudinal cohorts

This study will use state of the art analytic techniques to assist the association between calcium channel blocker use and the risk of breast cancer in longitudinal cohorts of Australian and Dutch women. This study will be the first to evaluate the risk in Australian women and the first to evaluate the risk across different populations using a standardised methodological approach.